Physical Activity in Severe Haemophilia A Patients on Long-Term Prophylaxis Treated with Helixate Nexgen

被引：0
|
作者：
Von Mackensen, S. [1 ]
Seuser, A. [2 ]
Tagliaferri, A. [3 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Inst Med Psychol, Hamburg, Germany
[2] Ctr Prevent Rehabil & Orthopaed, Bonn, Germany
[3] Univ Hosp Parma, Reg Reference Ctr Inherited Bleeding Disorders, Parma, Italy
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P049
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Adherence to prophylaxis in adult patients with severe haemophilia A
    Bonanad, S.
    Garcia-Dasi, M.
    Aznar, J. A.
    Mingot Castellano, E.
    Jimenez Yuste, V.
    Calle, M.
    Palma, A.
    Fernandez Lopez, M.
    Marco, P.
    Paloma, M.
    Perez Garrido, R.
    Fernandez Mosteirin, N.
    Galmes, B.
    Sanabria, M.
    Alvarez, M.
    HAEMOPHILIA, 2019, 25 : 166 - 167
  • [32] Adherence to prophylaxis in adult patients with severe haemophilia A
    Bonanad, Santiago
    Garcia-Dasi, Maria
    Aznar, Jose A.
    Eva Mingot-Castellano, Maria
    Jimenez-Yuste, Victor
    Victoria Calle, Ma
    Palma, Antonio
    Fernanda Lopez-Fernandez, Maria
    Marco, Pascual
    Jose Paloma, Maria
    Fernandez-Mosteirin, Nuria
    Galmes, Bernat
    Sanabria, Martin
    Pilar Alvarez, Ma
    HAEMOPHILIA, 2020, 26 (05) : 800 - 808
  • [33] Long-term outcome of individualized prophylactic treatment of children with severe haemophilia
    van den Berg, HM
    Fischer, K
    Mauser-Bunschoten, EP
    Beek, FJA
    Roosendaal, G
    van der Bom, JG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 561 - 565
  • [34] Continuous Long-Term Physical Activity Monitoring in Hemodialysis Patients
    Cohen, Brandon
    Munugoti, Samhitha
    Kotwani, Sonia
    Randhawa, Lovepreet S.
    Dalezman, Solomon
    Elters, Antonio C.
    Nam, Kate
    Ibarra, Jose S.
    Venkataraman, Sandheep
    Paredes, William
    Ohri, Nitin
    Abramowitz, Matthew K.
    KIDNEY360, 2022, 3 (09): : 1545 - 1555
  • [35] Alternations of oxidative stress markers in patients with severe haemophilia treated by different prophylaxis regimens
    Djunic, I
    Dopsaj, V
    Miljic, P.
    Novkovic, A.
    Suvajdzic-Vukovic, N.
    Tomin, D.
    Elezovic, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 353 - 353
  • [36] Long-Term Immunogenicity, Safety and Efficacy of Human-cl rhFVIII in Previously Treated Children with Severe Haemophilia A
    Klukowska, A.
    Vdovin, V.
    Szczepanski, T.
    Bichler, J.
    Dzhunova, I.
    Liesner, R.
    HAEMOPHILIA, 2016, 22 : 96 - 96
  • [37] Long-term immunogenicity, safety and efficacy of human-cl rhFVIII in previously treated children with severe haemophilia A
    Klukowska, Anna
    Vdovin, Vladimir
    Szczepanski, Tomasz
    Irena, Dzhunova
    Liesner, Raina
    Bichler, Johann
    HAEMOPHILIA, 2016, 22 : 52 - 52
  • [38] Patients with severe hamophilia on long-term prophylaxis are as physically active as the general Swedish population
    Khawaji, M. M.
    Berntorp, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1127 - 1127
  • [39] Retrospective 28-year long term follow-up of prophylaxis in a cohort of 49 patients with severe haemophilia A
    Oldenburg, J.
    Kraemer, L.
    Goldmann, G.
    Marquardt, N.
    Brackmann, H-H
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 133 - 133
  • [40] Long term follow up of secondary prophylaxis with RFVIIA in haemophilia patients with inhibitors
    Torres, O. W.
    Nascimento, P. D.
    Arbesu, G.
    Borchichi, S.
    Buceta, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 368 - 369
12345